David is the former CEO and co-founder of DJS Antibodies, a developer of a proprietary antibody discovery technology. He has more than 10 years’ experience in evolutionary immunology, antibody characterisation and myeloid cell biology, and led the DJS team in its pursuit to create transformational antibody therapeutics. David completed a PhD in Clinical Medicine at Oxford as a Rhodes Scholar. He also co-founded Beyond Equality, an organisation promoting positive masculinity and gender equality.